Kratos Defense & Security Solutions (KTOS) Q4 2024 earnings summary

Executive summary

• Achieved 2024 financial objectives with 9.6% revenue growth (9.1% organic), $1.136 billion in revenue, and strong cash flow from operations exceeding $45 million in Q4.

• Book-to-bill ratios were 1.5 in Q4 and 1.2 for the full year, with year-end backlog at $1.445 billion, indicating robust demand.

• Net income for 2024 was $16.3 million (GAAP EPS $0.11), reversing a net loss in 2023; Q4 net income was $3.9 million.

• Major new program wins, including the $1.5 billion MACH-TB 2.0 hypersonic award and Prometheus Energetics JV, set the stage for future growth.

• Positioned for sustained growth as U.S. and allies increase defense and strategic weapons funding.

Financial highlights

• Q4 2024 revenue was $283.1 million, with strength across unmanned systems, turbine technologies, microwave products, C5ISR, and defense rocket support.

• Adjusted EBITDA for 2024 was $105.7 million; Q4 Adjusted EBITDA was $25.2 million, reflecting a favorable revenue mix but offset by higher costs.

• Cash from operations in Q4 was $45.6 million; free cash flow was $32 million after $13.6 million in capex.

• Year-end cash and equivalents were $329.3 million, with no draw on $200 million credit line and $185 million on term loan.

• Full year 2024 operating income was $29.0 million; Adjusted EPS for 2024 was $0.49.

Outlook and guidance

• 2025 revenue guidance: $1.26–$1.285 billion, implying ~10% organic growth; 2026 organic revenue growth forecast of 13–15% over 2025.

• 2025 Adjusted EBITDA guidance: $112–$118 million; operating income: $34–$39 million.

• 2025 capex expected at $125–$135 million, with free cash flow use of $75–$85 million due to investments in new programs and facilities.

• Margin profile expected to improve by 100–150 basis points annually from 2026 through 2028 as contracts renew at higher rates and production ramps.

• Guidance assumes resolution of the U.S. government Continuing Resolution Authorization by March 14, 2025.